Last reviewed · How we verify
Nowarta110
At a glance
| Generic name | Nowarta110 |
|---|---|
| Sponsor | Nowarta Biopharma Inc |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Phase I/II Double-blind Safety and Efficacy Evaluation of Nowarta110 in Patients With Plantar Warts (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Nowarta110 CI brief — competitive landscape report
- Nowarta110 updates RSS · CI watch RSS
- Nowarta Biopharma Inc portfolio CI